Lourdes Weltzien Meridian Bioscience Inc (VIVO) insider trading activity

Lourdes Weltzien is Executive VP, Life Science of MERIDIAN BIOSCIENCE INC. Currently has a direct ownership of 0 shares of VIVO, which is worth approximately $0. The most recent transaction as insider was on Jan 31, 2023, when has been sold 86,045 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

LOURDES WELTZIEN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2023	SELL Sale (or disposition) back to the issuer	-	86,045 Reduced 100.0%	0 Common Stock
Jan 31 2023	BUY Grant, award, or other acquisition	-	7,945 Added 8.45%	86,045 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$139,479 $31.83 p/Share	4,382 Reduced 5.31%	78,100 Common Stock
Nov 04 2022	SELL Payment of exercise price or tax liability	$18,117 $32.01 p/Share	566 Reduced 0.68%	82,482 Common Stock
Feb 15 2022	SELL Open market or private sale	$512,000 $25.6 p/Share	20,000 Reduced 19.41%	83,048 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$289,600 $14.48 p/Share	20,000 Added 16.25%	103,048 Common Stock
Dec 15 2021	SELL Payment of exercise price or tax liability	$5,734 $17.92 p/Share	320 Reduced 0.38%	83,048 Common Stock
Nov 15 2021	SELL Payment of exercise price or tax liability	$86,063 $20.16 p/Share	4,269 Reduced 4.87%	83,368 Common Stock
Nov 15 2021	SELL Other acquisition or disposition	-	32,709 Reduced 37.32%	54,928 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	32,709 Added 27.18%	87,637 Common Stock
Nov 04 2021	BUY Grant, award, or other acquisition	-	10,593 Added 10.78%	87,637 Common Stock
Nov 23 2020	SELL Payment of exercise price or tax liability	$2,996 $19.08 p/Share	157 Reduced 0.2%	77,044 Common Stock
Nov 16 2020	SELL Payment of exercise price or tax liability	$42,929 $17.11 p/Share	2,509 Reduced 3.15%	77,201 Common Stock
Nov 05 2020	BUY Grant, award, or other acquisition	-	12,175 Added 13.25%	79,710 Common Stock

Lourdes Weltzien

Executive VP, Life Science

Cincinnati, OH

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIVO shares.

Notify only if

Value

Insider Trading

Get notified when an Meridian Bioscience Inc insider buys or sells VIVO shares.

Notify only if

Operation

Value

Type

News

Receive news related to MERIDIAN BIOSCIENCE INC

Track Activities on VIVO

Account